AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
Collegium Pharmaceutical
COLL
Cars.com
CARS
4
Workday
WDAY
5
eBay
EBAY
US Stock MarketDetailed Quotes
ACIU AC Immune
- 1.700
- 0.0000.00%
Close Apr 29 16:00 ET
170.70MMarket Cap-2.75P/E (TTM)
1.770High1.660Low104.85KVolume1.730Open1.700Pre Close178.86KTurnover0.26%Turnover RatioLossP/E (Static)100.41MShares4.97852wk High1.25P/B69.81MFloat Cap1.43052wk Low--Dividend TTM41.06MShs Float19.970Historical High--Div YieldTTM6.47%Amplitude1.430Historical Low1.705Avg Price1Lot Size
About AC Immune Company
AC Immune SA is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company was founded by Jean-Marie Lehn, Claude Nicolau, Roscoe Brady, Fred van Leuven, Ruth Greferath, Andrea Pfeifer, and Alexey V. Eleesiv on February 13, 2003 and is headquartered in Lausanne, Switzerland.
Company Profile
SymbolACIU
Company NameAC Immune
Listing DateSep 23, 2016
Issue Price11.00
Founded2003
CEODr. Andrea Pfeifer, PhD
MarketNASDAQ
Employees161
Fiscal Year Ends12-31
AddressEPFL Innovation Park,Building B
CityLausanne
ProvinceVaud
CountrySwitzerland
Zip Code1015
Phone41-21-345-91-21
Websitehttp://www.acimmune.com
Company Executives
- Name
- Position
- Salary
- Dr. Andrea Pfeifer, PhD
- Chief Executive Officer and Director
- --
- Piergiorgio Donati
- Chief Technical Operations Officer
- --
- Howard Donovan
- Chief Human Resources Officer
- --
- Christopher Roberts
- Chief Financial Officer
- --
- Dr. Anke Post, M.D.
- Chief Medical Officer
- --
- Mark Danton
- Executive Vice President, Information Systems and Artificial Intelligence
- --
- Dr. Olivier Sol, M.D.
- Vice President and Head of Clinical Development
- --
- Dr. Matthias Maurer, PhD
- Senior Vice President and General Counsel
- --
- Dr. Julien Rongere, PhD
- Senior Vice President, Regulatory Affairs and Quality Assurance
- --
- Dr. Gunther Staffler, PhD
- Senior Vice President, Immunotherapy
- --
- Dr. Gary Waanders, PhD
- Senior Vice President, Investor Relations and Corporate Communications
- --
- Dr. Francesca Capotosti, PhD
- Vice President, Research
- --
- Dr. Bojana Portmann, PhD
- Vice President, IP and Business Development
- --
- Professor Dr. Monika Butler, PhD
- Vice Chairman of the Board
- --
- Dr. Douglas E. WilliaPhD
- Chairman of the Board
- --
- Professor Dr. Carl June, M.D.
- Independent Director
- --
- Dr. Werner Lanthaler, PhD
- Independent Director
- --
- Dr. Roy Twyman, M.D.
- Independent Director
- --
- Dr. Monica Shaw, M.D.
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀